首页> 外文OA文献 >Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score

【2h】

Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score

机译：使用Dabigatran与Warfarin的低分子量肝素桥接在导管消融中进行心房颤动患者的低乍得2分

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Li Hao; Bing Rong; Fei Xie; Ming-Jie Lin; Jing-Quan Zhong;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin [J] . KonduruS.V., CheemaA.A., JonesP., Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing . 2012,第3期

机译：用达比加群治疗的患者与不间断使用华法林的患者在导管消融治疗房颤期间采用标准肝素剂量进行的术中ACT的差异
2. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin [J] . Sai V. Konduru, Aamir A. Cheema, Philip Jones, Journal of Interventional Cardiac Electrophysiology . 2012,第3期

机译：达比加群治疗的患者与不间断华法林治疗的患者在导管消融治疗房颤期间采用标准肝素剂量进行的术中ACT的差异
3. Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review [J] . Xiang-Min Shi, Fu-Kun Chen, Zhuo Liang, International Journal of Clinical and Experimental Medicine . 2015,第4期

机译：达比加群疗效是否足以预防围手术期导管射频消融期间CHADS2评分较高的房颤患者中风？病例报告并文献复习
4. Study on How Catheter Ablation Affects Atrial Structures in Patients with Paroxysmal Atrial Fibrillation: The Case of the Coronary Sinus [C] . Aikaterini Vraka, Vicente Bertomeu-González, Joaquín Osca, E-Health and Bioengineering Conference . 2020

机译：导管消融如何影响阵发性心房颤动患者心房结构的研究：冠状动脉窦的情况
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score [O] . Li Hao, Bing Rong, Fei Xie, -1

机译：低分子量肝素桥接达比加群与华法林在消融CHADS2评分较低的房颤患者中的应用
7. DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS [O] . Oldgren Jonas, Alings Marco, Darius Harald, 2010

机译：低，中，高CHADS2评分的房颤患者中DABIGATRAN VS WARFARIN的亚组分析

Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score

著录项

相似文献

相关主题

期刊订阅